Company Overview
About Omniscient Neurotechnology
Omniscient Neurotechnology (branded as o8t) is an Australian medical technology company founded in 2019 and headquartered in Sydney. Omniscient is the global pioneer of clinical connectomics — the application of brain network science to patient care. Its flagship product, Quicktome, is the world''s first FDA-cleared medical device to generate detailed maps of brain networks from standard MRI scans using artificial intelligence and machine learning. Neurosurgeons use Quicktome before life-changing brain surgeries to visualize critical functional networks (motor, language, vision, memory) and plan surgical approaches that minimize neurological damage.
Business Model & Competitive Advantage
In 2025, the National Reconstruction Fund Corporation (NRFC) led Omniscient''s Series D funding round with a $20 million preferred equity stake, with OIF Ventures co-investing, targeting a total raise of up to $36 million. Omniscient also announced a strategic partnership with The Jacobs Institute to launch the Connectomics Innovation Program, integrating connectomics into clinical research, patient care, and medical education — accelerating the translation of brain network science from research into routine clinical practice. Quicktome has US FDA clearance and is available to neurosurgery centers globally.
Competitive Landscape 2025–2026
Omniscient operates at the intersection of medical imaging, artificial intelligence, and neuroscience. Its technology processes diffusion-weighted MRI data to reconstruct white matter fiber tracts and overlay functional connectivity maps, giving surgeons a personalized atlas of each patient''s brain. The clinical connectomics field is nascent, with Omniscient holding a pioneering position. Applications extend beyond surgical planning to stroke rehabilitation, neurological disease monitoring, and neuroscience research, with the company targeting academic medical centers and high-volume neurosurgery programs worldwide.
Key Differentiators
Strong Challenger
Omniscient Neurotechnology is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
10x Genomics
10x Genomics was founded in 2012 in Pleasanton, California by Serge Saxonov, Ben Hindson, and Kevin Ness. The company developed the Chromium platform for single-cell RNA sequencing (scRNA-seq), enabli
Compare Omniscient Neurotechnology with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Omniscient Neurotechnology? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Omniscient Neurotechnology Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Omniscient Neurotechnology vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →